Evaluation of Alternative Oseltamivir (Tamiflu) Dosing Strategies.
Status:
Completed
Trial end date:
2007-02-01
Target enrollment:
Participant gender:
Summary
Objective 1: Determine the safety and toxicity profile of Tamiflu administered in combination
with probenecid in healthy adults.Objective 2: Determine the pharmacokinetic profile of
Tamiflu and probenecid in healthy adults.
Phase:
Phase 4
Details
Lead Sponsor:
US Department of Veterans Affairs VA Office of Research and Development
Collaborators:
Brooke Army Medical Center National Institutes of Health (NIH)